Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nektar Therapeutics

25.01
-0.0900-0.36%
Post-market: 24.75-0.2600-1.04%19:56 EDT
Volume:1.21M
Turnover:30.02M
Market Cap:432.70M
PE:-2.63
High:26.29
Open:24.82
Low:23.86
Close:25.10
Loading ...
Jun 15, 2021

Major Issues Report

8-K - Current report
May 07, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2021

Major Issues Report

8-K - Current report
Feb 26, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 17, 2021

Major Issues Report

8-K - Current report
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Jan 05, 2021

Major Issues Report

8-K - Current report
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 21, 2020

Major Issues Report

8-K - Current report
Nov 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 02, 2020

Major Issues Report

8-K - Current report
Aug 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]